Skip to main content

Table 1 Oncology drugs associated with stress cardiomyopathy

From: Chemotherapy-induced Takotsubo cardiomyopathy, a case report and review of the literature

Oncology drug(s) References
5-Fluorouracil Cheriparambil KM, et al. Angiology. 2000 [23]
Dalzell JR, et al. Anticancer Drugs. 2009 [24]
Gianni M, et al. Blood Coagul Fibrinolysis. 2009 [35]
Kobayashi N, et al. J Nippon Med Sch. 2009 [21]
Stewart T, et al. Intern Med J. 2010 [22]
Basselin C, et al. Pharmacotherapy. 2011 [25]
Radhakrishnan V, et al. J Pediatr Hematol Oncol. 2011 [19]
Grunwald MR, et al. J Clin Oncol. 2012 [26]
Ozturk MA, et al. Blood Coagul Fibrinolysis. 2013 [17]
Knott K, et al. Int J Cardiol. 2014 [20]
Capecitabine Qasem, et al. Am J Ther. 2014 [27]
Y-Hassan S, et al. Cardiovasc Revasc Med. 2013 [28]
Cytarabine Madias JE. Oncol Res Treat. 2015 [40]
Baumann S, et al. Oncol Res Treat. 2014 [37]
Cisplatin, docetaxel Toyooka S, et al. Gen Thorac Cardiovasc Surg. 2012 [38]
Cytarabine, daunorubicin Goel S, et al.World J Clin Cases. 2014 [33]
Paclitaxel, hydroxyurea, 5-Fluorouracil, concurrent radiation Schweizer MT, et al. J Clin Oncol. 2011 [41]
Axitinib Ovadia D, et al. J Clin Oncol. 2015 [30]
Sunitinib Numico G, et al. J Clin Oncol. 2012 [39]
Bevacizumab Franco TH, et al. Ther Clin Risk Manag 2008 [31]
Rituximab Smith SA, et al. Heart Fail Clin. 2013 [15]
Ng KH, et al. BMJ Case Rep. 2015 [32]
Trastuzumab Burgy M, et al. Anticancer Res. 2014 [42]
Khanji M, et al. Clin Oncol (R Coll Radiol) 2013 [43]
Cetuximab, irinotecan Kim L, et al. J Invasive Cardiol. 2008 [29]
Combretastatin Bhakta S, et al. Clin Cardiol. 2009 [18]